PASG FY 2020 Earnings — Passage Bio, Inc. Revenue & Financial Results | Market Cap Arena

PASGPassage Bio, Inc.

$28M

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$113M

Net Income

-$112M

EPS (Diluted)

$-57.80

Cash Flow

Operating Cash Flow

-$81M

Free Cash Flow

-$82M

Stock-Based Comp.

$15M

Balance Sheet

Total Assets

$328M

Total Liabilities

$23M

Stockholders' Equity

$305M

Cash & Equivalents

$135M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$113M	-$37M	-203.6%
Net Income	-$112M	-$46M	-145.9%